Repaglinide inhibits cyclosporine A-induced renal tubular toxicity by affecting apoptosis and Bax and Bcl-2 expression

Background/aim: Repaglinide (RG) is a prandial glucose regulator used for the treatment of type 2 diabetes. Our recent study showedthat RG plays an important role in cyclosporine A (CsA)-induced nephrotoxicity through its antioxidant properties. However, it isnot known whether or not RG has any protective effect on CsA-induced renal tubular toxicity by affecting apoptosis and expression ofapoptosis-associated protein. The purpose of this study was to investigate the effects of RG on CsA-induced renal tubule apoptosis andBax and Bcl-2 protein expression in rats.Materials and methods: Forty male Sprague Dawley rats weighing 250–300 g were randomly divided into four groups: administrationsof olive oil (control, per os (PO)), CsA (30 mg/kg in olive oil, subcutaneous (SC)), and RG (0.2 or 0.4 mg/kg, PO) plus CsA (30 mg/kgin olive oil, SC) every day for 15 days.Results: Our results showed that SC administration of CsA (30 mg/kg) to rats produced marked injury and apoptosis, elevation of Baxprotein expression, and inhibition of Bcl-2 protein expression in the kidneys, which were reversed significantly by oral administrationof RG (0.2 or 0.4 mg/kg).Conclusion: The findings of our study indicate that RG may play an important role in protecting the kidneys through inhibitingapoptosis, Bax, and Bcl-2 protein expression.

PDF

___

Li C, Choi DH, Choi JS. Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipine. J Pharmacokinet Phar 2012; 39: 99-108.
Polonsky KS, Given BD, Hirsch LJ, Tillil H, Shapiro ET, Beebe C, Frank BH, Galloway JA, Van Cauter E. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. New Engl J Med 1988; 318: 1231-1239.
Hasslacher C. Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function. Diabetes Care 2003; 26: 886-891.
Yale JF. Oral antihyperglycemic agents and renal disease: new agents, new concepts. J Am Soc Nephrol 2005; 16: 7-10.
Gumieniczek A. Oxidative stress in kidney and liver of alloxaninduced diabetic rabbits: effect of repaglinide. Acta Diabetol 2005; 42: 75-81.
Tankova T, Koev D, Dakovska L, Kirilov G. The effect of repaglinide on insulin secretion and oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pr 2003; 59: 43-49.
Naesens M, Kuypers DR, Sarwa M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephro 2009; 4: 481-508.
O’Connell S, Tuite N, Slattery C, Ryan MP, McMorrow T. Cyclosporine A-induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci 2012; 126: 101-113.
Ateşşahin A, Çeribaşı OA, Yılmaz S. Lycopene, a carotenoid, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rats. Basic Clin Pharmacol 2007; 100: 372- 376.
Hagar HH, Eman EE, Maha A. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin Exp Pharmacol P 2006; 33: 189–196.
Li D, Li J, Li H, Wu Q, Li QX. Antioxidant properties of repaglinide and its protections against cyclosporine A-induced renal tubular injury. Iranian Journal of Basic Medical Sciences 2016; 19: 744-749.
Justo P, Lorz C, Sanz A, Egido J, Ortiz A. Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. J Am Soc Nephrol 2003; 14: 3072-3080.
Pérez dHJ, De AG, Calvino M, Benito S, Parra T. Cyclosporin A causes oxidative stress and mitochondrial dysfunction in renal tubular cells. Nefrologia 2007; 27: 565-573.
Liu LL, Li QX, Xia L, Li J, Shao L. Differential effects of dihydropyridine calcium antagonists on doxorubicin-induced nephrotoxicity in rats. Toxicology 2007; 231: 81-90.
Gao H, Zhou YW. Inhibitory effect of picroside II on hepatocyte apoptosis. Acta Pharmacol Sin 2005; 26: 729-736.
Liu XH, Li J, Li QX, Ai YX, Zhang L. Protective effects of ligustrazine on cisplatin-induced oxidative stress, apoptosis and nephrotoxicity in rats. Environ Toxicol Phar 2008; 26: 45- 55.
Dolka I, Król M, Sapierzyński R. Evaluation of apoptosisassociated protein (Bcl-2, Bax, cleaved caspase-3 and p53) expression in canine mammary tumors: an immunohistochemical and prognostic study. Res Vet Sci 2016; 105: 124-133.
Hsu YT, Wolter KG, Youle RJ. Cytosol-to-membrane redistribution of Bax and Bcl-X (L) during apoptosis. P Natl Acad Sci USA 1997; 94: 3668-3672.
Dolka I, Motyl T, Malicka E, Sapierzyński R, Fabisiak M. Relationship between receptors for insulin-like growth factor-I, steroid hormones and apoptosis-associated proteins in canine mammary tumors. Pol J Vet Sci 2011; 14: 245-251.
Yıldırım F, Sönmez K, Özyoğurtçu H, Şennazlı G, Gürel A, Gündüz M, Sontaş BH. Evaluation of Bcl-2, Bcl-XL and Bax expression and apoptotic index in canine mammary tumours. Kafkas Univ Vet Fak 2014; 20: 513-520.
Davis MA, Ryan DH. Apoptosis in the kidney. Toxicol Pathol 1998; 26: 810-825.
Ueda N, Kaushal GP, Shah SV. Apoptotic mechanisms in acute renal failure. Am J Med 2000; 108: 403-415.
Rana A, Sathyanarayana P, Lieberthal W. Role of apoptosis of renal tubular cells in acute renal failure: therapeutic implications. Apoptosis 2001; 6: 83-102.